2024-11-17 - Analysis Report
## Intuitive Surgical Inc. (ISRG) Stock Analysis Report

**1. Performance Relative to S&P 500 (VOO):**

Intuitive Surgical Inc. (ISRG) is a company that manufactures and sells da Vinci surgical systems and related instruments and accessories.

The cumulative return of ISRG is 325.08%, significantly outperforming the S&P 500 (VOO) with a cumulative return of 123.86%.  The difference is 201.22%, placing it at the 97.56th percentile of its historical performance range relative to the S&P 500 (based on the provided min/max range).

The provided alpha and beta analysis shows consistently high alpha values (significantly outperforming the market) and a beta generally around 1.2, indicating higher-than-average volatility but also higher-than-average returns compared to the market.  The CAGR (Compound Annual Growth Rate) fluctuates, but consistently demonstrates substantial growth over the periods analyzed.  However, the Maximum Drawdown (MDD) also shows significant drawdowns in certain periods, highlighting the inherent risk associated with the stock.  Market capitalization has steadily increased over the years.

**2. Recent Price Movement:**

* **Closing Price:** $527.61 (Last Market: $527.57)
* **5-Day Moving Average:** $534.98
* **20-Day Moving Average:** $519.84
* **60-Day Moving Average:** $496.47

The stock is currently trading slightly below its 5-day moving average and above its 20-day and 60-day moving averages, suggesting a potential short-term pullback but overall upward trend.

**3. Technical Indicators:**

* **RSI (Relative Strength Index):** 63.03 – This indicates neither overbought nor oversold conditions, suggesting a neutral momentum.
* **PPO (Percentage Price Oscillator):** 0.17 – A positive value suggests a bullish momentum, although relatively weak.
* **Delta_Previous_Relative_Divergence:** -2.44 –  Indicates a recent short-term weakening of relative strength compared to the S&P 500.  The negative divergence should be viewed with caution.
* **Expected Return:** 2.28% – This represents the expected excess return over the S&P 500 for long-term (2+ years) investment.  However, this is a projected value and should not be taken as a guarantee.
* **527.57 vs. Previous Price:**  No information is provided on the previous price to assess the significance of 527.57.  Without this context, it’s impossible to comment on a sudden surge or decline.


**4. Recent Financial Performance and Outlook:**

The provided EPS and revenue data show consistent growth, though the rate of growth appears to be slowing somewhat.  The October 18th, 2024, earnings report shows strong numbers but lacks comparison to analyst estimates for a complete evaluation.  Analyzing the data alongside the analyst estimates and predictions is crucial for a thorough evaluation of the company's performance.

**5. Financial Information (Revenue and Profitability):**

The provided data reveals consistently high profit margins (above 65%), suggesting robust profitability.  Revenue growth shows some fluctuation, with strong performance in recent quarters. ROE (Return on Equity) shows variability but generally indicates positive returns on invested capital.

**6. Financial Information (Capital and Profitability):**

The equity has steadily increased, showing the company's growth and financial strength.  ROE shows variability, reflecting fluctuations in profitability and growth.  Consistent review of these indicators is necessary to evaluate long term trends and sustainability.

**7. News and Recent Issues:**

*(This section requires access to real-time news sources such as Shacknews and Finbold.  Please provide recent news articles for a comprehensive analysis.)*  A review of recent news articles from sources like Shacknews and Finbold, as well as analyst opinions from reputable financial sites, is necessary to gauge market sentiment, recent events impacting ISRG, and any significant developments affecting the outlook.


**8. Overall Analysis:**

ISRG has demonstrated a strong track record of outperformance compared to the S&P 500, with consistently high alpha values and significant revenue and profit growth.  However, the recent short-term price action and negative relative divergence raise some concerns, warranting closer monitoring.  The high MDD values in some periods highlight the significant risk associated with the investment. Long-term investment may be justified given the historical performance and positive growth outlook but requires careful attention to potential short-term volatility and market sentiment.  More information regarding recent news, analyst estimates for the October 18th, 2024 earnings report and current market forecasts are crucial for comprehensive evaluation.

**9. Disclaimer:**  This report is for informational purposes only and does not constitute financial advice.  Investing involves risk, and past performance does not guarantee future results.  Conduct thorough research and consider consulting a financial advisor before making any investment decisions.
